Trials
Search / Trial NCT05653960

Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry

Launched by CHINESE UNIVERSITY OF HONG KONG · Dec 15, 2022

Trial Information

Current as of February 05, 2025

Not yet recruiting

Keywords

Endoscopic Mucosal Resection Endoscopic Submucosal Dissection

ClinConnect Summary

Colorectal cancer (CRC) is one of the most common causes of cancer-related death, however its morbidity and mortality can be reduced by colonoscopy screening and endoscopic removal of adenomas or early cancers.\[1\] Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are two main endoscopic treatment options for colorectal neoplasms. Despite being a safe and convenient procedure, insufficient resection by EMR can result in a high risk of local recurrence, particularly in lesions ≥ 20 mm. Compared with EMR, ESD facilitates a higher rate of en bloc resection and a lo...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects who undergo EMR or ESD for colorectal lesions.
  • Exclusion Criteria:
  • Not applicable.

Trial Officials

Louis Lau

Principal Investigator

Prince of Wales Hospital

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Shatin, New Territories, Hong Kong

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials